The system STAR, an artificial intelligence-powered medical technique developed at Columbia University, has improved the detection of hidden sperm cells in men facing severe male factor infertility and azoospermia. According to medical researchers, male infertility accounts for up to 40 percent of all global infertility cases, presenting profound diagnostic and emotional challenges for couples worldwide.
Dr. Zev Williams, director of the Columbia University Fertility Center, noted that receiving a diagnosis of zero or extremely low sperm count is among the most devastating moments for patients. Traditional manual microscopic examination of ejaculate can take up to eight hours and frequently misses rare, isolated sperm cells hidden among billions of cellular debris fragments. To combat this limitation, Dr. Williams and his research team spent approximately seven years developing the Sperm Tracking and Recovery (STAR) system, which officially launched at the end of 2025.
The STAR system processes semen samples by injecting them into a microfluidic chip roughly the size of a stick of gum. Fluid travels through a microscopic channel narrower than a human hair, where a high-power magnifying lens paired with a high-speed camera captures roughly 300 images per second. A connected computer runs machine learning algorithms to instantly analyze the visual data. When the artificial intelligence identifies a single sperm cell, it triggers a tiny lateral valve in the microfluidic channel to isolate and capture the cell for standard in vitro fertilization procedures.
Dr. Williams likened the technology to astronomical exploration. When you look at the night sky with the naked eye, you can see many stars, but using a telescope reveals much more, providing capabilities that go far beyond human visual limitations.
Clinical data from 175 cases demonstrate that the STAR system successfully located and recovered sperm in 26 percent of attempts. In one documented case, a patient’s sample analyzed via micro-TESE yielded no sperm over two days of manual review, whereas the STAR system detected 44 sperm cells within just one hour. Another notable clinical milestone involved a couple experiencing 19 years of infertility; following a STAR analysis of a 39-year-old male patient’s sample, sperm was recovered, resulting in the birth of a girl.
Addressing Wider Infertility Trends and Scientific Horizons
While artificial intelligence enhances the recovery of rare sperm cells, researchers continue to study broader trends in male reproductive health. A prominent 2017 meta-analysis indicated that sperm counts among western men had declined by roughly half over a 40-year span, prompting warnings from environmental medicine experts like Shanna Swan, professor of environmental medicine and public health at the Mount Sinai School of Medicine in New York, who suggested that assisted reproduction could become necessary for most couples by mid-century.
Conversely, other medical research, including a 2025 study led by urologists at the Cleveland Clinic, found stable sperm concentrations among fertile American men over the past fifty years. Dr. Alexander Pastuszak, a board-certified urologist, executive director, and co-founder of Paterna Biosciences, observed that medical opinion remains divided while acknowledging a growing consensus that male reproductive challenges require sustained scientific innovation.
In parallel with diagnostic tools like the STAR system, private biotechnology firms are exploring regenerative approaches. Paterna Biosciences, based in Utah, reported experimental laboratory cultivation of human sperm cells from testicular tissue stem cells using a proprietary chemical mixture in a petri dish. While these preliminary findings await independent replication and peer-reviewed publication, researchers view such developments as potential future avenues for individuals who do not produce sperm.
Current Availability and Future Medical Outlook
At present, the STAR system remains operational exclusively at Columbia University, where clinical experts utilize three dedicated units. The primary objective for the development team moving forward is to create a more automated system that can be used by other fertility clinics.
Medical professionals emphasize the emotional significance of recovering even a single viable gamete for prospective parents who previously faced total reproductive finality. The research team continues to track ongoing clinical pregnancies achieved through the system as they prepare further updates on assisted reproductive technology advancements.
Related reading